FDA prevails over EMA in 2025 novel drug approvals
Pharmaceutical Technology·Trump unveils health care plan aimed at lowering costs
Yahoo Finance·- President Donald Trump announced a multi-part proposal on January 14 aimed at reducing prescription drug prices and health insurance costs while increasing price transparency. - The plan suggests disbursing funds directly to consumers instead of insurance companies and comes as debates continue regarding the extension of enhanced subsidies under the Affordable Care Act. - Several proposals have been pushed by Trump or Congress, building on measures from his first term and recent agreements with pharmaceutical companies for "most favored nation" drug pricing.